drugset / Trial / NCT01731002
Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Double-masked, randomized, multi-center, dose-response, active-controlled parallel-comparison of AR-13324 to latanoprost
Timeline
- Start
- 2012-11
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Latanoprost | Small molecule | 0.005 % | — |
| Subject | Netarsudil | Small molecule | 0.01 % | — |
| Subject | Netarsudil | Small molecule | 0.02 % | — |